New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

2016/07/15 by Emma Beard, Lion Shahab, Damian M. Cummings +2 · 36 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Bupropion #Cytisine #Internal medicine #Medicine #Nicotine #Nicotine replacement therapy #Nicotinic Acetylcholine Receptors Study #Nicotinic agonist #Pharmacology #Psychiatry #Respiratory and Cough-Related Research #Smoking Behavior and Cessation #Smoking cessation #Varenicline

paper · doi:10.1007/s40263-016-0362-3

published in CNS Drugs 30(10), 951-983 (Springer Science and Business Media LLC)

crossref issued 2016/07/15 · crossref published 2016/07/15 · crossref published-online 2016/07/15 · openalex publication_date 2016/07/15 · crossref created 2016/07/15 · crossref published-print 2016/10/01 · crossref deposited 2023/08/19 · openalex created_date 2025/10/10 · crossref indexed 2026/02/03 · openalex updated_date 2026/07/29

Citations

• Individualisation of drug treatments for patients with long-term conditions: a review of concepts
• Low-tar medium-nicotine cigarettes: a new approach to safer smoking.
• Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit
• Cytisine for Smoking Cessation
• Effect on smoking cessation of silver acetate, nicotine and ordinary chewing gum

Cited by

• The messages presented in online electronic cigarette promotions and discussions: a scoping review protocol
• Electronic cigarette [wikipedia]